PubMed Health⌕ Search

Biomedical subjects

G Brunner

Publications and source records attributed to G Brunner.

At least 91 records · Page 5Linked to original sources

[A chronic destructive non-suppurative cholangitis-like disease picture with antinuclear antibodies (immunocholangitis)].

Three females had suffered, two for many years, from bouts of a liver disease of unknown origin, which clinically, histologically and biochemically fulfills the criteria of chronic destructive non-suppurative cholangitis. None of the patients had antimitochondrial antibodies, but all had antinuclear antibodies at high titres. Two of them are mother and daughter; the latter has two daughters (aged 10 and 12 years), both of whom have antinuclear antibodies at low titres but no abnormal liver function tests. The female family members of the third patient also had antinuclear antibodies in their serum with normal liver enzyme tests. None of the patients was taking any drugs. Contrary to true chronic destructive nonsuppurative cholangitis (primary biliary cirrhosis), in the three patients immunosuppressive treatment with azathioprine (Imurek) and prednisone (Decortin) was successful. It is suggested that the described disease be called immunocholangitis.

Adult↗

Enzymatic synthesis and chromatographic purification of lignan glucuronides.

Enterolactone, enterodiol and secoisolariciresinol were conjugated with glucuronic acid by solubilized rabbit liver microsomal UDP-glucuronyltrasnferase. The monoglucuronide conjugate of all three substrates was formed and its identity confirmed by nuclear magnetic resonance (NMR) spectroscopy. Analytical high pressure liquid chromatography (HPLC) and NMR spectroscopy indicated conjugation with glucuronic acid to occur at several positions in the molecule. The enzymatic conjugation was monitored by analytical capillary isotachophoresis (ITP). The Km-values for enterlactone, enterodiol, and secoisolariciresinol were calculated to be 0.30, 0.23, and 0.22 mmol/l respectively.

Animals↗

Enzyme-based hemoperfusion and blood treatment.

Enzyme-based artificial organs are being developed as metabolic assist devices. These are required when normal metabolism is impaired, or when the body is overloaded by undesired metabolites or toxins. The implementations of this approach for treating a genetic disease, and for metabolic support in liver failure are envisaged. The kinetic aspects and mass transfer characteristics of bioreactors for these systems are considered in detail.

Blood↗

Enzymatic detoxification using lipophilic hollow-fiber membranes: II. Sulfation reactions.

A lipophilic hollow-fiber technique was used in the enzymatic sulfation of lipophilic toxins. Endogenous and exogenous toxins, for which glucuronidation reactions already were demonstrated with this technique, were submitted to sulfate transferase reaction as an alternative phase-II detoxification route. Native enzyme was circulated on the external side of a lipophilic hollow-fiber membrane while the toxin-containing media (serum or aqueous solution) were circulated inside the hollow fiber. Sulfation reactions were catalyzed by rabbit liver cytosol, with a specific sulfate transferase activity of 626 nmol/min-mg protein. Clearance of the hollow-fiber module for phenol, p-cresol, paracetamol, 2-aminophenol, and 5-hydroxyindol were determined to be 38.1, 47.2, 2.7, 5.3, and 3.2 pmol/mg protein/h/cm2 hollow-fiber surface, respectively. This technique allows sulfation reactions with crude enzyme preparations over long periods without loss of activity from covalent immobilization and without immunological hazards.

Acetaminophen↗

[Artificial liver support 1985].

Many techniques have been developed to support liver function in patients with hepatic failure. Only two of these methods are suited to be used in adequately equipped hospitals under appropriate safety conditions. Exchange of toxin-rich patient plasma against fresh frozen plasma will decrease plasma toxin levels and substitute coagulation factors and proteins. This procedure however should be used in intervals of at least 3-4 days because more frequent application will lead to lung or cerebral complications. Dialysis and hemofiltration will remove water soluble toxins from patient blood as well as excess amino acids which are considered to be precursors of toxic lipophilic metabolites. Addition of certain amino acids to dialysis fluid in physiological concentrations will help to avoid loss of essential amino acids (with approx. normal plasma concentration). In a very few special centers treatment by liver perfusion of human or pavian livers, or by liver transplantation can be performed.

Blood↗

Adsorption and desorption characteristics of nucleotide based coenzymes on agarose encapsulated resins for long term cofactor supply of enzymatic reactions.

In order to find optimal long term cofactor supply for continuous enzymatic detoxification processes, different resins of varying surface, dipole moment, pore size, and chemical structure were investigated for their adsorptive capacity as well as their desorption behaviour towards various nucleotide based coenzymes. UDPGA, NADPGH, NADH, and SAM were gently shaken with agarose coated resins XAD-12, XAD-8, XAD-7, XAD-4, XAD-2, Dowex 1 X 2 (50-100; 200-400), Dowex 1 X 4 (20-50; 200-400), Dowex 2 X 8, and charcoal until all nucleotide was adsorbed or a saturation of the resins was achieved. High adsorption capacity was not always found to correlate with a steady release of cofactor in desorption experiments. Under this premise the optimal resin-cofactor combinations for long term cofactor supply were found to be XAD-12 for UDPGA, Dowex 2 X 8 for NADPH, Dowex 1 X 4 (20-50) for NADH, and XAD-7 for SAM.

Adsorption↗

Separation of plasma membrane proteins of cultured human fibroblasts by affinity chromatography on bonded microparticulate silicas.

Adsorbents for high-performance affinity chromatography were prepared by bonding proteins and reactive Procion triazine dyes to 3-isothiocyanatopropyl- and 3-aminopropylsilicas. The materials prepared were used successfully in the separation of hydrophobic plasma membrane proteins of cultured human fibroblasts. The data obtained show that the reaction of 3-isothiocyanatopropyltriethoxysilane (ITCPS) with the surface hydroxyl groups of silica yields a new and convenient route to preparing an "activated carrier" that is capable of coupling with potential affinity ligands containing amino functional groups. The reaction and bonding procedures of 3-isothiocyanatopropyltriethoxysilane and 3-aminopropyltriethoxysilane with silica were optimized with regard to a controlled and reproducible ligand density by adjusting the type of solvent and organic base as reaction catalyst. The ligand content of reactive triazine dyes directly coupled to 3-aminopropylsilica was significantly higher than that of the 6-aminohexyl derivatives coupled to 3-isothiocyanatopropylsilica. The stability of Procion Blue MX-R bonded to 3-aminopropylsilica and 3-isothiocyanatopropylsilica in phosphate-buffered aqueous solution at pH 5.0 and 8.0 was examined.

Cell Membrane↗

[Ranitidine and cimetidine in the prevention of stress: ulcer hemorrhage a prospective comparative multicenter study].

In a multicentre single-blind study, ranitidine was compared to cimetidine as prophylactic treatment against stress-induced upper gastrointestinal bleeding in seriously ill patients in the intensive care unit (ICU). 380 patients entered the study. 192 patients were treated with ranitidine 50 mg q.i.d. as i.v. bolus followed by 150 mg orally twice daily. 188 patients received cimetidine 400 mg q.i.d. intravenously and 1,000 mg daily orally in divided doses. Five patients in the ranitidine group (2.6%) and 12 in the cimetidine group (6.4%) developed gastrointestinal bleeding definitely or possibly due to stress lesions. This difference was not significant. The incidence of stress erosions or ulcerations developing during the study was 11.8% for the ranitidine group and 18.3% for the cimetidine group (non-significant difference). Adverse events in the ranitidine group were nausea, tachycardia or vomiting in 4 patients. 5 cimetidine-treated patients developed cholestasis, and 5 additional central nervous system problems. The high degree of efficacy of both drugs compared very favourably with the high incidence of stress ulceration and hemorrhage in similar untreated populations.

Adolescent↗

Enzymatic detoxification using lipophilic hollow-fiber membranes: I. Glucuronidation reactions.

A lipophilic hollow-fiber membrane preparation was used in the enzymatic detoxification of lipophilic toxins. Native enzymes were circulated on one side of the lipophilic membrane, while the toxin-containing media (blood, serum, waste fluids, etc.) were circulated inside the hollow fiber. Lipophilic substances that accumulate in and penetrate the lipophilic membrane were converted by the corresponding enzymes. Phase II detoxifying enzymes converted the lipophilic toxins to hydrophylic compounds that made a rediffusion of these molecules back to the blood impossible. Glucuronidation reactions were catalyzed by a crude preparation of solubilized uridine-5'-diphosphate-glucuronyltransferase (EC 2.1.1.9) with a specific activity of 10.0 nmol/min/mg protein in the presence of uridine-5'- diphosphoglucuronic acid (acceptor: phenol as reference substrate). Clearance rates of phenol, 1- naphthol , 2- naphthol , and p-cresol were measured, respectively, to be 141, 195, 300, and 251 pmol/h/mg protein/cm2 hollow fiber. The advantage of this technique lies in the possibility of using highly active, soluble enzyme preparations and a fully utilizable cofactor supply. The lipid membrane ensures the absence of immunological hazards, while mass transfer of the toxin is not impaired.

Cresols↗

[Electrophysiologic studies in neuropathies].

The value of the electrophysiological investigations can be summarized as follows: Differentiation of different types of polyneuropathies. Detection of subclinical neuropathies. Approach to etiopathogenical aspects. Verification of therapeutic results. Prognosis. The single questions are discussed.

Axons↗

[Incidence of peptic ulcer in an inpatient angiologic patient sample].

Incidence of peptic ulcers in hospitalized patients with arterial occlusive disease without history or clinical symptoms of ulcer disease was 32% and four times higher than in patients with acute phlebothrombosis. Possible etiological factors could be: decreased blood perfusion of gastric or duodenal mucosa because of generalized arteriosclerosis, intake of ulcerogenic drugs, chronic abuse of nicotine, and stress due to the underlying arterial occlusive disease. Patients with inflammatory vascular disease are affected as often as are patients with arteriosclerotic disease. Routine endoscopic examination of the upper GI-tract should be performed in such patients in order to exclude potential bleeding sources before treatment with fibrinogen lowering drugs is started.

Adolescent↗

[Progress on the way to an "artificial liver"].

Recently lipophilic fluid membrane hollow fiber modules have been developed, which allow continuous extracorporal enzymatic detoxification by elimination of endogenous toxins out of the blood in vivo without loss of enzymatic activity and without immunological risks. The clearance for phenol glucuronisation is 6.8 nMol/min/mg enzyme protein/cm2 hollow fiber surface the hydroxylation rate for dodecanic acid using the cytochrome - P-450 system is 0.5 nMol/nMol P450/min/cm2 hollow fiber surface. Detoxification procedures using methyl, sulfat and glutathion transferase are still in an experimental phase. This new enzyme fluid membrane technology in conjunction with modified established techniques like aminoacid dialysis and plasma exchange will make possible the development of partial extracorporal substitution of liver function in the near future.

Amino Acids↗